Trekking in Nepal | Adventure Altitude Treks & Expedition
COVID-19 Updates

COVID-19 Updates

COVID-19 Updates

CoViD-19 updates: Recent updates about Corona Virus in Nepal

Nepal has started its vaccination program after receiving the Covishield CoViD-19 vaccines as a donation from the Indian Government. Covishield is a vaccine developed by Oxford University in collaboration with AstraZeneca. The vaccine is regionally produced by the Serum Institute of India. Nepal received 1 million doses of vaccines as a donation from the Indian Government. Also, the Government of Nepal has approved the use of the Chinese CoViD-19 vaccine, Vera Cell, under the condition that they must be used in case of emergency only.

The government of Nepal has completed its first phase of the CoViD-19 vaccination program by vaccinating 184,857 people. The first phase of vaccination was given to health work professionals including doctors, nurses, ambulance drivers, and female community health workers. The second phase of the program has started on February 15. The government has been using Covishield vaccines till now but will receive vaccines under WHO's Covax program soon enough. In the second phase, vaccines are being administered to journalists, media personnel, security personnel, civil servants, border security personnel, besides health workers, ambulance drivers, sanitation staff, and community female health workers who missed the program in the first phase of the campaign.

Some of the guidelines, for people traveling this beautiful country, have been removed. The compulsory 7-day quarantine has been removed but you will still need to provide a 72-hour negative PCR test before arriving here as you have to show the proof to the airline personnel. Once you landed here and complete the process, you don't have to stay in quarantine which means you can start organizing your stuff, start planning. But if you start showing symptoms of CoViD-19, you are immediately asked for a PCR test and have to stay in isolation until you get a negative test.